Article
In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.
Future microbiology - 1 Jul 2017
Rifat Dalin, Campodónico Victoria L, Tao Jing, Miller James A, Alp Alpaslan, Yao Yufeng, Karakousis Petros C
Abstract excerpt
AIM: There is controversy regarding the potential fitness costs of rifampicin (RIF) resistance-conferring mutations in the Mycobacterium tuberculosis (Mtb) rpoB gene. We characterized the pathogenicity of an Mtb RpoB H526D mutant. MATERIALS & METHODS: A mutant containing the RpoB H526D mutation was isolated from wild-type Mtb grown on RIF-containing plates and complemented for determination of in vitro and in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
